Abstract
Summary
Injection of high doses of KT-FeLV feline leukemia virus produced both viremia and leukemia in a portion of 1- to 2-day-old kittens but not in 17- to 24-week-old animals. Contact of susceptible cats with infected cagemates did not result in viremia or disease. Development of cytotoxic antibody was coordinated with protection against viremia and disease in kittens challenged with FeL V virus. The rapid evolution of resistance to KT-FeLV virus precluded the development of a practical means for conventional vaccination and challenge experiments in cats. Killed vaccine given to pregnant queens did, however, afford protection against FeLV virus on challenge in the progeny.
Get full access to this article
View all access options for this article.